Bio-Rad Laboratories Inc

Healthcare · Medical Devices

379.60$ +0.6% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Bio-Rad Laboratories Inc (BIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 10,577 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BIO
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	285	352	367	669	646	684	721	993	1,372	1,427	1,596	1,972	2,037	2,536	3,063	3,097	3,444	3,389	3,341	3,710	3,851	4,273	5,611	8,009	12,973	17,799	13,502	12,299	9,364	10,577
Current Assets	199	227	235	379	370	431	466	655	908	1,008	1,130	1,029	1,094	1,563	1,975	1,798	1,937	1,757	1,716	1,778	1,845	1,977	2,023	2,180	2,140	1,990	3,158	3,048	3,030	2,906
Cash	9.4	11	10	17	14	47	28	65	196	297	224	162	205	650	907	574	463	332	413	458	456	384	432	661	662	471	434	404	488	532
Cash & Short-Term Investments	9.4	11	10	17	14	47	28	149	362	413	488	224	243	745	1,025	813	921	609	698	786	839	755	845	1,115	991	870	1,791	1,607	1,665	1,543
Receivables	98	97	106	194	182	194	212	234	261	247	293	358	340	346	388	399	399	423	378	391	372	465	392	393	419	424	495	489	453	473
Inventory	70	91	92	126	133	139	166	190	206	212	253	321	376	351	398	434	455	516	471	490	525	595	584	554	622	572	719	781	760	741
Property, Plant & Equipment	–	–	–	–	119	133	142	179	202	180	190	272	301	302	18	350	417	429	429	438	489	493	509	499	491	696	499	724	689	710
Goodwill	–	–	–	–	91	76	70	70	113	113	119	328	322	328	364	469	495	518	500	496	477	506	220	264	292	347	407	414	411	580
Intangible Assets	–	28	19	105	91	76	70	82	172	142	45	210	229	205	204	260	261	266	254	214	162	174	133	146	200	254	332	321	294	174
Total Liabilities	101	155	153	449	402	400	338	497	775	769	777	1,000	967	1,257	1,522	1,352	1,428	1,202	1,156	1,219	1,271	1,343	1,591	2,254	3,093	4,114	3,886	3,558	2,795	3,123
Current Liabilities	79	101	97	203	189	199	222	239	315	319	320	414	418	420	667	459	472	487	447	441	471	503	451	905	632	681	569	523	468	517
Short-Term Debt	5.6	11	9.4	22	18	9.9	7.5	10	9.5	3.3	3.0	16	9.6	5.1	233	0.8	1.8	1.8	0.3	0.3	0.3	0.4	0.5	462	38	37	37	41	43	38
Accounts Payable	21	32	27	65	63	65	75	54	71	73	83	96	118	93	113	129	131	149	129	122	133	135	122	107	139	142	135	145	122	129
Long-Term Debt	–	–	–	–	203	188	106	226	426	426	426	442	446	738	731	732	732	436	436	434	434	435	439	14	12	11	1,198	1,199	1,200	1,203
Shareholders' Equity	184	197	214	220	245	284	383	496	597	658	820	972	1,041	1,260	1,537	1,744	2,015	2,187	2,185	2,491	2,579	2,930	4,020	5,755	9,880	13,685	9,615	8,741	6,569	7,454
Retained Earnings	151	167	190	201	232	277	345	421	489	571	674	762	852	996	1,182	1,360	1,528	1,606	1,695	1,808	1,829	1,830	3,722	5,471	9,268	13,525	9,898	9,261	7,416	8,176
Shares Outstanding	25	25	25	24	25	25	26	26	26	27	27	27	28	28	28	28	29	29	29	29	30	30	30	30	30	30	30	29	28	27

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings